Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15794493 | 1.00 | KIF11 (0.75) | KIF11DNMT1 | |
| SCHEMBL15794494 | 1.00 | KIF11 (0.75) | KIF11DNMT1 | |
| SCHEMBL14537475 | 0.91 | KIF11 (0.70) | KIF11DNMT1 | |
| SCHEMBL14537466 | 0.91 | KIF11 (0.72) | KIF11DNMT1 | |
| SCHEMBL14537457 | 0.87 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL14537459 | 0.87 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL14537476 | 0.87 | KIF11 (0.60) | KIF11DNMT1 | |
| SCHEMBL14432808 | 0.87 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL14548760 | 0.87 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL14537458 | 0.82 | KIF11 (0.55) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4234537-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | FUJIFILM Corporation (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-20230258569-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | FUJIFILM CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| WO-2022085762-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | 富士フイルム株式会社 | 2022-04-28 | — | — | WO | disclosed |
| US-8765817-B1 | Selective inhibitors of EG5 motors and methods of use | ARROWHEAD CENTER, INC. (US) | 2014-07-01 | — | — | US | disclosed |
| US-8765817-B1 | Selective inhibitors of EG5 motors and methods of use | ARROWHEAD CENTER, INC. (US) | 2014-07-01 | — | — | US | disclosed |
| US-8349899-B1 | Selective inhibitors of EG5 motors and methods of use | ARROWHEAD CENTER, INC. (US) | 2013-01-08 | — | — | US | disclosed |
| US-8349899-B1 | Selective inhibitors of EG5 motors and methods of use | ARROWHEAD CENTER, INC. (US) | 2013-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230258569-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | TST, CUTA, HNMT | KIF11 4229/4885DNMT1 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.